Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background and objective An elevated heart rate (HR) is an independent risk factor for mortality and morbidity in patients with acute heart failure (HF). The purpose of this study was to evaluate the impact of ivabradine, a selective HR-lowering agent, in patients with cardiogenic shock (CS) complicating ST-elevation acute myocardial infarction (AMI). Methods Patients with post-AMI CS were randomized to standard treatment (SDT, 28 patients) or to standard treatment plus ivabradine (I + SDT, 30 patients). In the presence of orotracheal intubation (OTI), ivabradine was administered by nasogastric intubation. HR, BP, New York Heart Association (NYHA) class, NT-proBNP, left ventricular ejection fraction (LVEF) and diastolic function (LVDF) were monitored at specific times after the onset of AMI. The primary (surrogate) end-point was the in-hospital halving of plasma NT-proBNP levels. The secondary end-points were cardiovascular death, hospital re-admission for worsening HF, and clinical and haemodynamic improvement. Results Treatment groups were statistically similar with regard to age, gender distribution, cardiovascular risk factors, number of diseased vessels and overall treated lesions, AMI site and occurrence of OTI. In-hospital mortality was double in the SDT group in comparison with the I + SDT group (14.3 vs. 6.7 %), but the difference was not statistically significant. HR, BP, NT-proBNP and LVEF favorably changed in both groups, but the change was more relevant in the I…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beyond chronic ambulatory HF, small studies have shown that the additional use of ivabradine with a β-blocker is safe and well tolerated in hospital settings.”
From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [68]
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61171-x · Cited by 789 · cited 1×
“Moreover, patients with AHF and a HR[70 beats/ min have a significantly greater CV mortality and risk for hospital admission than those with a HR\70 beats/min [2].”
BackgroundLechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., & Ferrari, R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406430 · Cited by 486 · cited 1×
“On the basis of these limited sample-size observations, but also because of the disappointing results of the SIGNIFY trial [17], it can be assumed that the HR-lowering effect of ivabradine administration is beneficial, in terms of significant outcomes, in clinical syndromes where a depressed LV function activates a ne…”
ResultTardif, J.-C., O'Meara, E., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Tavazzi, L., & Swedberg, K. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr311 · Cited by 300
Heusch, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707673 · Cited by 245
Lechat, P., Escolano, S., Golmard, J. L., Lardoux, H., Witchitz, S., Henneman, J. A., Maisch, B., Hetzel, M., Jaillon, P., Boissel, J.-P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.7.2197 · Cited by 206
Metra, M., Torp-Pedersen, C., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Komajda, M., Remme, W. J., Lutiger, B., Scherhag, A., Lukas, M. A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi386 · Cited by 178
Borer, J. S., Bohm, M., Ford, I., Komajda, M., Tavazzi, L., Sendon, J. L., Alings, M., Lopez-de-Sa, E., Swedberg, K., & on behalf of the SHIFT Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs259 · Cited by 142
Cited by
McDonald, M., Virani, S., Chan, M., Ducharme, A., Ezekowitz, J. A., Giannetti, N., Heckman, G. A., Howlett, J. G., Koshman, S. L., Lepage, S., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.017 · Cited by 287
Metadata
- Authors
- Barillà, F., Pannarale, G., Torromeo, C., Paravati, V., Acconcia, M. C., Tanzilli, G., Mangieri, E., Dominici, T., Martino, F., Pannitteri, G., & Gaudio, C.
- Affiliations
- Sapienza University of Rome (IT)
- Corresponding author
- Barillà, Francesco
- ORCID
- Venue
- Clinical Drug Investigation
- Published
- 2016-06-16
- Volume
- 36
- Issue
- 10
- Pages
- 849-856
- ISSN
- 0114-2402 (ISSN-L)
- 1173-2563
- 1179-1918
- OpenAlex
- W2425075297
- Cited by
- 51
- References
- 17
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 10 · 2023: 1 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Drug Investigation (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- ivabradine, cardiogenic shock, ST-elevation myocardial infarction, heart rate reduction, NT-proBNP, left ventricular diastolic function, in-hospital mortality, acute heart failure, nasogastric tube insertion, left ventricular ejection fraction
- MeSH terms
- ST Elevation Myocardial Infarction, Ivabradine, Acute Disease, Adult, Aged, Benzazepines, Cardiovascular Agents, Female, Heart Failure, Humans, Male, Middle Aged, Peptide Fragments, Prospective Studies, Risk Factors, Shock, Cardiogenic, Ventricular Function, Left, Natriuretic Peptide, Brain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study. https://app.cochat.ai/papers/10.1007/s40261-016-0424-9
- The paper
- Barillà, F., Pannarale, G., Torromeo, C., Paravati, V., Acconcia, M. C., Tanzilli, G., Mangieri, E., Dominici, T., Martino, F., Pannitteri, G., & Gaudio, C. (2016). Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study. Clinical Drug Investigation. https://doi.org/10.1007/s40261-016-0424-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.